Intra-Cellular Therapies, Inc. (ITCI)

Intra-Cellular Therapies Revenue

Intra-Cellular Therapies had revenue of $175.38M in the quarter ending September 30, 2024, with 39.00% growth. This brings the company's revenue in the last twelve months to $613.73M, up 46.08% year-over-year. In the year 2023, Intra-Cellular Therapies had annual revenue of $464.37M with 85.51% growth.

• Revenue (ttm): $613.73M
• Revenue Growth: +46.08%
• P/S Ratio: 20.70
• Revenue / Employee: $1,006,111
• Employees: 610
• Market Cap: 13.41B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	464.37M	214.06M	85.51%
Dec 31, 2022	250.31M	166.51M	198.69%
Dec 31, 2021	83.80M	60.99M	267.35%
Dec 31, 2020	22.81M	22.75M	37,537.14%
Dec 31, 2019	60.61K	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.